CEVA
CEVA, Inc. NASDAQ Listed Nov 1, 2002$33.71
Mkt Cap $939.1M
52w Low $17.02
93.5% of range
52w High $34.87
50d MA $22.10
200d MA $23.21
P/E (TTM)
-73.4x
EV/EBITDA
-925.6x
P/B
2.3x
Debt/Equity
0.1x
ROE
-3.2%
P/FCF
1013.2x
RSI (14)
—
ATR (14)
—
Beta
1.53
50d MA
$22.10
200d MA
$23.21
Avg Volume
425.7K
CEVA, Inc. operates as a licensor of wireless connectivity and smart sensing technologies to semiconductor and original equipment manufacturer (OEM) companies worldwide. It designs and licenses various digital signal processors, AI processors, wireless platforms, and complementary software for sensor fusion, image enhancement, computer vision, voice input, and artificial intelligence (AI). The company licenses a family of wireless connectivity and smart sensing technologies, and integrated IP solutions, including DSP-based platforms for 5G baseband processing in mobile, IoT, and infrastructure; imaging and computer vision for any camera-enabled devices; audio/voice/speech and ultra-low power always-on/sensing applications for multiple IoT markets; sensor fusion software and inertial measurement unit solutions for hearables, wearables, AR/VR, PC, robotics, remote controls, and IoT; and wireless IoT for Bluetooth, Wi-Fi 4/5/6/6E, Ultra-wideband (UWB), and NB-IoT. Its technologies are licensed to companies, which design, manufacture, market, and sell application-specific integrated circuits and application-specific standard products to mobile, consumer, automotive, robotics, industrial, aerospace and defense, and IoT companies for incorporation into various end products. The company delivers its DSP cores, platforms, and AI processors in the form of a hardware description language definition; and offers development platforms, software development kits, and software debug tools that facilitate system design, debug, and software development. The company licenses its technology through a direct sales force. The company was formerly known as ParthusCeva, Inc. and changed its name to CEVA, Inc. in December 2003. CEVA, Inc. was incorporated in 1999 and is headquartered in Rockville, Maryland.
15245 Shady Grove Road · Rockville, MD 20850 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17, 2026 | AMC | 0.18 | 0.18 | +0.0% | 20.45 | -2.2% | -1.8% | -3.8% | -4.8% | -8.3% | -1.6% | — |
| Nov 10, 2025 | AMC | 0.10 | 0.11 | +10.0% | 26.01 | +3.8% | +0.3% | +4.9% | -4.0% | -5.5% | -9.3% | — |
| Aug 11, 2025 | AMC | 0.05 | 0.07 | +40.0% | 21.33 | +0.8% | +10.6% | +14.3% | +13.0% | +9.3% | +11.2% | — |
| May 7, 2025 | AMC | 0.07 | 0.06 | -14.3% | 21.14 | +0.0% | -4.3% | -5.0% | +1.8% | +4.9% | +4.7% | — |
| Feb 13, 2025 | AMC | 0.11 | 0.11 | +0.0% | 34.96 | +2.8% | -0.8% | +2.3% | +2.8% | +4.6% | -1.3% | — |
| Nov 7, 2024 | AMC | 0.09 | 0.14 | +55.6% | 29.34 | +2.2% | -3.6% | -4.1% | -4.6% | -5.6% | -6.7% | — |
| Aug 7, 2024 | AMC | 0.02 | 0.17 | +628.8% | 19.44 | +4.7% | +5.2% | +5.1% | +3.8% | +11.7% | +15.0% | — |
| May 9, 2024 | AMC | -0.01 | -0.05 | -292.5% | 20.25 | -1.4% | -3.2% | -3.9% | -0.8% | +0.7% | -0.4% | — |
| Feb 14, 2024 | AMC | 0.06 | 0.10 | +66.7% | 24.51 | +2.0% | -0.1% | -6.0% | -7.3% | -8.0% | -8.9% | — |
| Nov 8, 2023 | AMC | 0.04 | 0.02 | -44.4% | 19.68 | +1.8% | -4.8% | +1.1% | +1.5% | +11.7% | +13.0% | — |
| Aug 9, 2023 | AMC | 0.08 | -0.02 | -125.0% | 22.06 | -3.1% | -0.4% | -2.0% | -6.0% | -8.1% | -10.2% | — |
| May 10, 2023 | AMC | 0.12 | -0.16 | -233.3% | 21.31 | -1.5% | -1.0% | -1.5% | +1.4% | +0.0% | +0.6% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 8 | JP Morgan | Initiates | Neutral | $30 | — | — | — | — | — | — | — | — |
| Mar 12 | Rosenblatt | Maintains | Buy → Buy | — | $19.87 | $19.50 | -1.9% | -7.4% | -8.2% | -6.1% | -6.9% | -6.8% |
| Feb 18 | Oppenheimer | Maintains | Outperform → Outperform | — | $20.45 | $20.00 | -2.2% | -1.8% | -3.8% | -4.8% | -8.3% | -1.6% |
| Feb 18 | Rosenblatt | Maintains | Buy → Buy | — | $20.45 | $20.00 | -2.2% | -1.8% | -3.8% | -4.8% | -8.3% | -1.6% |
| Nov 12 | Barclays | Maintains | Overweight → Overweight | — | $26.08 | $26.80 | +2.8% | +4.6% | -4.3% | -5.8% | -9.6% | -22.7% |
| Nov 11 | Rosenblatt | Maintains | Buy → Buy | — | $26.01 | $26.99 | +3.8% | +0.3% | +4.9% | -4.0% | -5.5% | -9.3% |
| Aug 14 | Rosenblatt | Maintains | Buy → Buy | — | $24.37 | $23.78 | -2.4% | -1.1% | -4.3% | -2.7% | -7.0% | -8.9% |
| May 9 | Oppenheimer | Maintains | Outperform → Outperform | — | $20.24 | $20.51 | +1.3% | -0.8% | +6.3% | +9.5% | +9.4% | +5.4% |
| May 8 | Barclays | Maintains | Overweight → Overweight | — | $21.14 | $21.14 | +0.0% | -4.3% | -5.0% | +1.8% | +4.9% | +4.7% |
| May 8 | Rosenblatt | Maintains | Buy → Buy | — | $21.14 | $21.14 | +0.0% | -4.3% | -5.0% | +1.8% | +4.9% | +4.7% |
| Apr 23 | Rosenblatt | Maintains | Buy → Buy | — | $23.50 | $24.45 | +4.0% | +8.6% | +13.0% | +13.7% | +13.1% | +12.7% |
| Feb 14 | Rosenblatt | Maintains | Buy → Buy | — | $34.96 | $35.95 | +2.8% | -0.8% | +2.3% | +2.8% | +4.6% | -1.3% |
| Feb 14 | Barclays | Maintains | Overweight → Overweight | — | $34.96 | $35.95 | +2.8% | -0.8% | +2.3% | +2.8% | +4.6% | -1.3% |
| Feb 11 | Rosenblatt | Maintains | Buy → Buy | — | $32.73 | $32.13 | -1.8% | -1.8% | -3.1% | +6.8% | +5.9% | +9.3% |
| Dec 23 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $31.11 | $31.20 | +0.3% | +2.3% | +3.7% | +6.7% | +4.1% | +3.0% |
| Nov 8 | Rosenblatt | Maintains | Buy → Buy | — | $29.34 | $30.00 | +2.2% | -3.6% | -4.1% | -4.6% | -5.6% | -6.7% |
| Nov 8 | Roth MKM | Maintains | Buy → Buy | — | $29.34 | $30.00 | +2.2% | -3.6% | -4.1% | -4.6% | -5.6% | -6.7% |
| Oct 31 | Rosenblatt | Maintains | Buy → Buy | — | $24.42 | $24.37 | -0.2% | -4.4% | -3.0% | -3.2% | -2.1% | +3.1% |
| Aug 8 | Roth MKM | Upgrade | Neutral → Buy | — | $19.44 | $20.36 | +4.7% | +5.2% | +5.1% | +3.8% | +11.7% | +15.0% |
| Aug 8 | Oppenheimer | Maintains | Outperform → Outperform | — | $19.44 | $20.36 | +4.7% | +5.2% | +5.1% | +3.8% | +11.7% | +15.0% |
| May 10 | Roth MKM | Maintains | Neutral → Neutral | — | $20.25 | $19.96 | -1.4% | -3.2% | -3.9% | -0.8% | +0.7% | -0.4% |
| Feb 13 | Rosenblatt | Maintains | Buy → Buy | — | $21.93 | $20.84 | -5.0% | -7.9% | +11.8% | +11.7% | +5.1% | +3.6% |
| Dec 7 | Rosenblatt | Maintains | Buy → Buy | — | $21.79 | $22.11 | +1.5% | -1.2% | -0.7% | +4.4% | +1.7% | +3.3% |
| Aug 11 | Barclays | Maintains | Overweight → Overweight | — | $21.97 | $21.64 | -1.5% | -1.6% | -5.6% | -7.7% | -9.8% | -7.2% |
| Aug 10 | Barclays | Maintains | Overweight → Overweight | — | $22.06 | $21.37 | -3.1% | -0.4% | -2.0% | -6.0% | -8.1% | -10.2% |
| Aug 10 | Rosenblatt | Maintains | Buy → Buy | — | $22.06 | $21.37 | -3.1% | -0.4% | -2.0% | -6.0% | -8.1% | -10.2% |
| Aug 10 | Roth MKM | Downgrade | Buy → Neutral | — | $22.06 | $21.37 | -3.1% | -0.4% | -2.0% | -6.0% | -8.1% | -10.2% |
| Aug 10 | Northland Capital Markets | Maintains | Outperform → Outperform | — | $22.06 | $21.37 | -3.1% | -0.4% | -2.0% | -6.0% | -8.1% | -10.2% |
| May 11 | Barclays | Maintains | Overweight → Overweight | — | $21.31 | $21.00 | -1.5% | -1.0% | -1.5% | +1.4% | +0.0% | +0.6% |
| May 11 | TD Cowen | Maintains | Outperform → Outperform | — | $21.31 | $21.00 | -1.5% | -1.0% | -1.5% | +1.4% | +0.0% | +0.6% |
| May 11 | Oppenheimer | Maintains | Outperform → Outperform | — | $21.31 | $21.00 | -1.5% | -1.0% | -1.5% | +1.4% | +0.0% | +0.6% |
| May 11 | Roth MKM | Maintains | Buy → Buy | — | $21.31 | $21.00 | -1.5% | -1.0% | -1.5% | +1.4% | +0.0% | +0.6% |
| Feb 17 | Barclays | Maintains | Overweight → Overweight | — | $32.65 | $32.97 | +1.0% | +1.1% | -2.1% | -2.7% | -1.3% | -3.0% |
| Feb 16 | Cowen & Co. | Maintains | Outperform → Outperform | — | $34.66 | $34.98 | +0.9% | -5.8% | -4.8% | -7.7% | -8.3% | -7.1% |
| Nov 11 | Barclays | Maintains | Overweight → Overweight | — | $28.19 | $28.00 | -0.7% | +0.4% | -0.6% | +3.0% | +0.6% | +1.0% |
| Nov 10 | Rosenblatt | Maintains | Buy → Buy | — | $26.05 | $27.38 | +5.1% | +8.2% | +8.7% | +7.6% | +11.4% | +8.9% |
| Feb 16 | Rosenblatt | Upgrade | Neutral → Buy | — | $40.00 | $41.24 | +3.1% | +4.8% | +0.7% | +0.3% | -2.4% | -4.7% |
| May 11 | Northland Capital Markets | Upgrade | Market Perform → Outperform | — | $42.40 | $42.25 | -0.4% | +7.9% | +0.2% | -3.2% | +0.8% | +0.8% |
| May 11 | Barclays | Upgrade | Equal Weight → Overweight | — | $42.40 | $42.25 | -0.4% | +7.9% | +0.2% | -3.2% | +0.8% | +0.8% |
| Feb 17 | Roth Capital | Maintains | Buy → Buy | — | $74.11 | $73.00 | -1.5% | -3.8% | -9.5% | -5.2% | -9.4% | -10.6% |
| Sep 21 | Northland Capital Markets | Upgrade | Market Perform → Outperform | — | $36.86 | $37.00 | +0.4% | +0.9% | +2.6% | -0.6% | +1.1% | +2.2% |
| Mar 30 | Northland Securities | Upgrade | Market Perform → Outperform | — | $21.05 | $21.73 | +3.2% | +12.8% | +18.4% | +16.8% | +23.7% | +22.2% |
| Mar 30 | Northland Capital Markets | Upgrade | Market Perform → Outperform | — | $21.05 | $21.73 | +3.2% | +12.8% | +18.4% | +16.8% | +23.7% | +22.2% |
| Aug 9 | Canaccord Genuity | Maintains | Buy → Buy | — | $31.40 | $32.15 | +2.4% | -3.2% | -0.9% | +2.1% | +0.3% | -1.6% |
| Apr 17 | Exane BNP Paribas | Downgrade | Outperform → Neutral | — | $27.78 | $25.07 | -9.8% | -13.6% | -16.1% | -14.4% | -13.6% | -11.4% |
| Feb 14 | Northland Capital Markets | Downgrade | Outperform → Market Perform | — | $28.59 | $27.41 | -4.1% | -3.3% | +1.2% | -0.1% | +0.1% | +0.4% |
| Feb 14 | Northland Securities | Downgrade | Outperform → Market Perform | — | $28.59 | $27.41 | -4.1% | -3.3% | +1.2% | -0.1% | +0.1% | +0.4% |
| Oct 16 | Canaccord Genuity | Maintains | Buy → Buy | — | $24.96 | $25.85 | +3.6% | +9.6% | +8.2% | +4.9% | +3.6% | +2.8% |
| Aug 8 | Barclays | Maintains | Overweight → Overweight | — | $27.60 | $27.40 | -0.7% | +3.4% | +7.6% | +7.2% | +6.2% | +7.2% |
| May 10 | Canaccord Genuity | Maintains | Buy → Buy | — | $30.05 | $29.70 | -1.2% | +0.7% | +2.5% | +5.2% | +7.2% | +9.0% |
No insider trades available.
8-K · 5.02
!!! Very High
CEVA Inc. -- 8-K 5.02: Executive Change
CEVA Inc. loses executive Sven-Christer Nilsson as he declines re-election, potentially signaling leadership transition and uncertainty for investors monitoring the semiconductor IP company's strategic direction.
Apr 20
8-K
CEVA Inc. -- 8-K Filing
CEVA Inc. reported fourth quarter and full year 2025 financial results, with CFO Yaniv Arieli disclosing earnings that investors should evaluate for revenue trends and profitability metrics.
Feb 17
Data updated apr 25, 2026 12:50am
· Source: massive.com